| # | Drug | Count |
|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 56 |
| 1 | INSULIN LISPRO | 45 |
| 2 | NALTREXONE | 20 |
| 3 | INSULIN GLARGINE | 15 |
| 4 | INSULIN HUMAN | 15 |
| 5 | TREPROSTINIL | 12 |
| 6 | ASPIRIN | 11 |
| 7 | LEVOTHYROXINE SODIUM | 11 |
| 8 | ASPIRIN 325 MG | 10 |
| 9 | ASPIRIN 81 MG | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 1 | HUMAN IMMUNOGLOBULIN G | 56 | 0.0027 |
| 2 | GARADACIMAB | 2 | 0.0026 |
| 3 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 10 | 0.0024 |
| 4 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 5 | METRELEPTIN | 3 | 0.0024 |
| 6 | HUMAN RHO(D) IMMUNE GLOBULIN | 2 | 0.0019 |
| 7 | SEBETRALSTAT | 1 | 0.0019 |
| 8 | PYRITHIONE ZINC | 1 | 0.0016 |
| 9 | APOMORPHINE HYDROCHLORIDE | 2 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 60 |
| 1 | Insulin Analog [EPC] | 57 |
| 2 | GLP-1 Receptor Agonist [EPC] | 18 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 4 | Insulin [EPC] | 17 |
| 5 | Prostacycline Vasodilator [EPC] | 12 |
| 6 | Interferon beta [EPC] | 11 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 9 | Loop Diuretic [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 60 | 0.0028 |
| 1 | Leptin Analog [EPC] | 3 | 0.0024 |
| 2 | Cytolytic Agent [EPC] | 1 | 0.0004 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 5 | Insulin [EPC] | 17 | 0.0004 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Insulin Analog [EPC] | 57 | 0.0001 |
| 9 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |